Jenny Epstein

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. ncbi Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease
    Jenny Epstein
    Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, London E1 2AT, UK
    Br J Nutr 103:824-32. 2010
  2. ncbi Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
    Jenny Epstein
    Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, 4 Newark Street, London E1 2AT, UK
    Br J Nutr 103:1545-57. 2010

Collaborators

Detail Information

Publications2

  1. ncbi Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease
    Jenny Epstein
    Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, London E1 2AT, UK
    Br J Nutr 103:824-32. 2010
    ..We demonstrate dose-dependent suppression of MMP-3 in CMF with curcumin. We conclude that curcumin, a naturally occurring food substance with no known human toxicity, holds promise as a novel therapy in IBD...
  2. ncbi Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
    Jenny Epstein
    Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, 4 Newark Street, London E1 2AT, UK
    Br J Nutr 103:1545-57. 2010
    ..We review the evidence for the therapeutic potential of curcumin from in vitro studies, animal models and human clinical trials...